Synaptotagmin I and neurexin I mRNAs, coding for proteins involved in neurotransmitter secretion, become detectable in primary sympathetic ganglia shortly after initial induction of the noradrenergic transmitter phenotype. To test whether the induction of these more general neuronal genes is mediated by signals known to initiate noradrenergic differentiation in a neuronal subpopulation, we examined their expression in noradrenergic neurons induced by ectopic overexpression of growth and transcription factors. Overexpression of BMP4 or Phox2a in vivo results in synaptotagmin I and neurexin I expression in ectopically located noradrenergic cells. In vitro, BMP4 initiates synaptotagmin I and neurexin I expression in addition to tyrosine hydroxylase induction. Thus, the induction of synaptotagmin I and neurexin I, which are expressed in a large number of different neuron populations, can be accomplished by growth and transcription factors available only to a subset of neurons. These findings suggest that the initial expression of proteins involved in neurotransmitter secretion is regulated by different signals in different neuron populations. q
Introduction
During neuronal differentiation, precursor cells acquire characteristic functional properties. Examples of such properties include the ability to conduct action potentials and to transmit encoded information to target cells at chemical synapses. Apart from such general neuronal features, the expression of specific properties allows to distinguish neurons belonging to different classes. Whereas chemical neurotransmission constitutes such a general neuronal property, the actual neurotransmitter molecule(s) secreted differs between different classes of nerve cells. In sympathetic ganglia, noradrenergic and cholinergic neurons coexist which secrete noradrenaline and acetylcholine as transmitter, respectively (for review see Ernsberger and Rohrer, 1999) .
The different neurotransmitter molecules may elicit opposite regulatory changes, vasoconstriction and vasodilation, respectively, in muscle arteries, allowing an extended repertoire of physiological adaptive responses. A fascinating problem concerning the development of diversity in nervous response patterns is to understand how the induction of general neuronal properties and the expression of classspecific features is coordinated during neuronal differentiation. The analysis of the induction of the neurotransmitter phenotype in sympathetic neurons in some molecular detail provides the possibility for a comparison with the development of neuronal features such as neurotransmitter secretion.
In the chick sympathetic nervous system, the temporal expression pattern of the noradrenergic neurotransmitter synthesis machinery has been analyzed in detail (Ernsberger et al., 1995 . BMP growth factors produced in the dorsal aorta are sufficient to induce noradrenergic differentiation (Reissmann et al., 1996; Ernsberger et al., 2000) and their blockade by noggin (a natural inhibitor of BMP signaling) prevents the expression of noradrenergic and pan-neuronal properties (Schneider et al., 1999) . Also in mammalian embryos, BMPs are expressed in the dorsal aorta and can induce noradrenergic differentiation in neural crest stem (Shah et al., 1996; Lo et al., 1999) . In addition, Phox2 transcription factors can evoke the expression of noradrenergic and pan-neuronal properties in avian embryos (Stanke et al., 1999) and the inactivation of the Phox2b gene in mice results in the lack of noradrenergic differentiation of sympathetic precursors (Pattyn et al., 1999) . Knowing about the induction of the noradrenergic neurotransmitter synthesis machinery (Ernsberger, 2000) , we were interested to see whether the expression of molecules involved in neurotransmitter vesicle exocytosis is regulated in a comparable fashion.
Synaptotagmins are synaptic vesicle proteins with the ability to bind calcium ions, phospholipids and other presynaptic proteins (Südhof and Rizo, 1996) . Gene inactivation studies in vertebrates and invertebrates indicate that synaptotagmins are critical for evoked neurotransmitter release and may function as low-affinity calcium sensors for vesicle fusion (Littleton et al., 1993; Nonet et al., 1993; . Neurexins are presynaptic transmembrane proteins (Missler and Südhof, 1998) which can bind to different intra-and extracellular ligands including synaptotagmins (Hata et al., 1993) . They have been hypothesized to structure synaptic connections (Butz et al., 1998) and can affect vesicle fusion and transmitter release (Sugita et al., 1999) . In contrast to synaptotagmins, neurexins are expressed in neurons but not in neuroendocrine cells of the adrenal medulla (Ushkaryov et al., 1992; Marquèze et al., 1995) . Even though neurexins are known to be expressed embryonically during neurite outgrowth in neurons (Püschel and Betz, 1995; Patzke and Ernsberger, 2000) and synaptotagmin expression can be regulated by target contact (Lou and Bixby, 1995; Campagna et al., 1997; Plunkett et al., 1998) , it is unknown what processes lead to the induction of their expression during development.
Here we demonstrate that synaptotagmin I and neurexin I are detectable with only a short delay after noradrenergic induction in embryonic sympathetic neurons. Moreover, their expression can be induced by BMP4 in vitro and in vivo. Both mRNAs are detectable in ectopic neurons induced along the course of nerves by Phox2a overexpression. The data indicate that the regulation of synaptotagmin I and neurexin I, proteins expressed in many neuronal populations, may overlap with the regulation of the subclassspecific noradrenergic neurotransmitter phenotype.
Results

Synaptotagmin I and neurexin I are expressed early during sympathetic neuron differentiation
To analyze when synaptotagmin I and neurexin I are first detectable during differentiation of sympathetic neurons, in situ hybridization was performed on sections of chick embryonic tissue in the thoracic region. At embryonic stage 20 (st 20, Hamburger and Hamilton, 1951) , mRNA for synaptotagmin I is detectable in primary sympathetic ganglia (Fig. 1) . Neurexin I mRNA becomes detectable at st 21 (Fig. 1) . These stages correspond to a time point less than half a day after noradrenergic induction in cells of the primary sympathetic ganglia (Ernsberger et al., 1995 .
Synaptotagmin I and neurexin I signals in sympathetic ganglia are weak at this early developmental stage and increase with ongoing development. At embryonic day 18 (E18) the synaptotagmin I signal is stronger in sympathetic neurons than in DRG neurons or spinal cord ( Fig. 2A,B) . Also, the neurexin I signal increases in intensity until E18 but remains still less intense than in DRG or spinal cord neurons (Patzke and Ernsberger, 2000) . Synaptotagmin II is not detectable by in situ hybridization in sympathetic neurons at any developmental stage analyzed through E18 (Fig. 2C) . Similarly, in the rat, a differential expression of Fig. 1 . Expression of synaptotagmin I and neurexin I in primary sympathetic ganglia of the chick embryo. Cross sections at thoracic levels of stage 21 (A,B) and stage 20 (C,D) embryos were hybridized with radiolabeled cRNA probes for neurexin I (A), tyrosine hydroxylase (TH) (B,D), and synaptotagmin I (C). Hybridization signal for TH shows the location of the primary sympathetic ganglia (arrows) adjacent to the dorsal aorta (a). A weak but distinct signal for neurexin I and synaptotagmin I is seen in these positions. In addition, expression is detectable in the neural tube (n). Scale bar: 50 mm.
synaptotagmin I and II has been observed in the sympathetic system with synaptotagmin I expressed in postganglionic neurons (Ullrich et al., 1994) .
Synaptotagmin I and neurexin I expression is induced by BMP4 overexpression in chick embryos
TH and DBH, enzymes of the noradrenergic transmitter biosynthesis cascade, are induced by BMPs during sympathetic neuron differentiation (Reissmann et al., 1996; Schneider et al., 1999; Ernsberger et al., 2000) . The close correlation of their expression indicates a common regulation as a synexpression group (Niehrs and Pollet, 1999) . As synaptotagmin I and neurexin I expression are detectable shortly after expression of noradrenergic properties, we were interested to see whether BMPs could also induce the expression of these two genes.
For this purpose, BMP4 was overexpressed by infection of developing embryos with an RCAS-BMP4 retrovirus which generates clusters of ectopic noradrenergic cells dorsolateral to the spinal nerve (Reissmann et al., 1996; Ernsberger et al., 2000) . These clusters were analyzed for expression of synaptotagmin I and neurexin I by in situ hybridization in 8-day-old embryos in which infected fibroblasts were implanted on embryonic day 2. In all three RCAS-BMP4-infected embryos analyzed, synaptotagmin I and neurexin I expression were observed in the clusters of DBH (Fig. 3) and TH (not shown)-expressing ectopic cells and double in situ hybridization demonstrated TH in synaptotagmin I-positive cells (Fig. 4) . Preprotachykinin expression, which is detectable in sensory and spinal cord neurons of corresponding stages in vivo, is not detectable in ectopic noradrenergic cells (data not shown).
The expression of synaptotagmin and neurexin 6 days after implantation of infected cells might result from a cascade of inductive events, as the initial effects of BMP4 Fig. 3 . Synaptotagmin I and neurexin I are expressed in ectopic noradrenergic cells in RCAS-BMP4-treated embryos. A chick embryo was infected with RCAS-BMP4 by implanting infected fibroblasts adjacent to the neural tube at embryonic day 2. At embryonic day 8, embryos were fixed, cryosectioned and processed for in situ hybridization. DIG-labeled cRNA probes for dopamine b-hydroxylase (A), synaptotagmin I (B), and neurexin I (C) applied to adjacent sections demonstrate mRNA expression in a cluster of ectopically located noradrenergic cells. Dorsal is to the top and medial to the left. The cluster of labeled cells starts adjacent to the developing vertebral body located outside the left margin of the figure and extends almost all the way to the dorsolateral epithelium located outside the upper right corner of the figure. No noradrenergic cells are observed in comparable positions of control embryos. The cell cluster shown in this figure is from a different RCAS-BMP4-infected embryo but the same position as the boxed area in Fig. 4 . Scale bar: 50 mm. expression would be expected several days earlier. Therefore, we also analyzed these effects in 5-day-old embryos (3 days after transplantation of infected fibroblasts). From four embryos tested by in situ hybridization for TH mRNA, clusters of ectopic cells were observed in 1 embryo, enlarged sympathetic ganglia on the side were the infection was placed could be observed in this and two other embryos, whereas one embryo did not show an effect. These observations, which are in line with our earlier observations (Reissmann et al., 1996) , indicate that the effects of virally mediated overexpression of BMP4 on sympathoadrenal development are first apparent at this stage. Synaptotagmin I mRNA was expressed in the ectopic TH-positive cell clusters and enlarged ganglia, albeit at low levels that did not allow double in situ hybridization (data not shown). These results indicate that synaptotagmin I expression in excess catecholaminergic cells induced by BMP4 overexpression commences during the same time period as TH expression, comparable to normal development. The low levels of synaptotagmin I mRNA in the excess neurons are comparable to those observed in normal sympathetic ganglia of this developmental stage, suggesting that the differentiation program in these excess cells proceeds along a similar schedule to that of the normal sympathetic neurons.
Induction of synaptotagmin I and neurexin I in neural crest cultures by BMP4
After infection with RCAS-BMP4 virus, the time course of BMP4 overexpression in the vicinity of migrating neural crest and differentiating primary sympathetic ganglion cells is not well defined. In vitro, a brief treatment with BMP4 is sufficient to induce noradrenergic differentiation in neural crest cultures (Reissmann et al., 1996) . To analyze whether this also suffices to induce the expression of synaptotagmin I and neurexin I expression in these cells, cultures were treated for 1 day with 10 ng/ml BMP4 after replating the dissociated cells. Following this treatment, BMP4 was removed by carefully washing the culture dishes with medium or BMP was blocked by addition of excess noggin (Schneider et al., 1999) . After 5 additional days of culturing, cells were analyzed by in situ hybridization. Removal of BMP4 by either treatment led to the appearance of ganglion-like cell aggregates that were strongly positive for TH mRNA ( Fig.  5A -D) and were not observed in control cultures grown in the complete absence of exogenously added BMPs (compare Reissmann et al., 1996) . In addition, neurite-like processes were regularly seen to extend from these clusters. Synaptotagmin I and neurexin I were also expressed in the aggregates ( Fig. 5E-H) . Expression levels appeared lower than those of TH and DBH, as was observed in vivo during normal development and in ectopic cells after viral infection (see above). Due to the strong clustering of the cells, a quantitative analysis of the number of cells expressing the respective mRNAs was not attempted. In the continuous presence of BMP4, such a clustering into ganglion-like aggregates is not observed (compare Reissmann et al., 1996) . Therefore, the induction of TH and synaptotagmin I was quantitatively analyzed in the continuous presence of BMP4 in neural crest cell cultures.
Cell density differently affects synaptotagmin I and tyrosine hydroxylase induction by BMP4 in neural crest cultures
Synaptotagmin I and TH each become detectable around the same time in sympathetic neuron development in vivo, and both are induced by BMP4 in vivo and in vitro. Still, the slightly later appearance of synaptotagmin I as well as the slow increase in expression levels in vivo indicate that there are differences in regulation as compared to TH. This is supported by differences in their regulation in neural crest cell culture in the continuous presence of BMP4 (Fig. 6) . The cultures were analyzed by in situ hybridization after 6 days of BMP4 treatment, 2 days after TH-positive cells become detectable (Reissmann et al., 1996) .
BMP treatment led to an increase in the number of synaptotagmin I and TH-positive cells as compared to untreated cultures (Fig. 6A,B) . The effect was less pronounced for synaptotagmin I compared to TH expression. The number of synaptotagmin I-positive cells was highly variable, ranging from an average of 40-260 positive cells/mm 2 in six independent experiments in the presence of 10 ng/ml BMP4. Also the density of catecholaminergic cells varied from experiment to experiment, ranging from 70 to 650 THpositive cells/mm 2 . Interestingly, there was no apparent correlation between the degree of synaptotagmin I and TH induction. In fact, the culture with the highest number of TH-positive cells showed the lowest number of synaptotagmin I-positive cells.
As factors in the culture medium including those secreted from the cultured cells themselves can be expected to affect neural crest cell differentiation, the cultures were analyzed for the distribution of positive cells as a function of cell density and distance to the cell-free surroundings of the wells in which the cells were plated. When plotted against local cell density, the percentage of positive cells in a field strongly increased with cell density for synaptotagmin I but not for TH (Fig. 6C,D) . At high cell densities, the number of TH-positive cells as a percentage of total cells was reduced rather than increased (Fig. 6D) , suggesting that very high cell densities may compromise the development of catecholaminergic characters under these culture conditions. Whereas the number of TH-positive cells exceeds the number of synaptotagmin I-positive cells in regions of low cell density, no such difference is observed in regions of high cell density (Fig. 6C,D) . Comparing the percentage of synaptotagmin I-positive cells in regions of high and low cell density shows that increased cell density in the absence of BMP4 does not result in an increased proportion of synaptotagmin I-positive cells (Fig. 6E) . In the presence of BMP4, however, the induction of synaptotagmin I expression changes from 8-to 30-fold when cell density increases from 1000 to 1600 cells/mm 2 on average. Determining the percentage of positive cells per unit area as a function of position in the well, synaptotagmin I was found to be expressed at strongly increased levels in the center of the well as compared to the margins (Fig. 6F ). For TH, no significant differences were found when different regions of the well were compared (not shown). Taken together, our results suggest that the conditioning of the medium by surrounding cells affects synaptotagmin I expression. As the correlation between final cell density and mRNA expression is observed for synaptotagmin I and not for TH, factors in addition to the presence of BMP4 affect TH and synaptotagmin I expression differently.
Because double in situ hybridization in culture was not feasible, it could not be directly verified that all synaptotagmin I-positive cells in vitro were also TH-positive. The following evidence, however, suggests that the synaptotagmin I-expressing cells belong to a sympathoadrenal lineage. The culture conditions including serum and embryo extract favor sympathoadrenal and obstruct sensory development in neural crest culture (Ziller et al., 1987) . In fact, the cells displaying TH and synaptotagmin I signals in our neural crest cultures were of irregular shape, often polygonal as shown for TH-expressing cells (Reissmann et al., 1996) . They do not show bipolar morphology with the phasebright round to oval somata described for neural crest-derived cells expressing sensory properties (Ziller et al., 1987) and for DRG-derived precursors differentiating into sensory neurons (Ernsberger and Rohrer, 1988) . In addition, the coexpression of synaptotagmin I and TH after BMP4 overexpression in vivo (Fig. 4) suggests that the synaptotagmin I-expressing cells observed after BMP4 treatment in vitro belong to a sympathoadrenal lineage.
Induction of synaptotagmin I and neurexin I expression by Phox2 transcription factors in vivo
Phox2 transcription factors are implicated in the induction of noradrenergic properties in sympathetic neurons as they are expressed during the time of noradrenergic induction (Ernsberger et al., 1995 Pattyn et al., 1999) , induce noradrenergic properties in vitro (Stanke et al., 1999; Lo et al., 1999) and are sufficient and necessary for the expression of noradrenergic properties in vivo (Stanke et al., 1999; Pattyn et al., 1999) . In addition, Phox2 transcription factors are sufficient to induce the expression of the pan-neuronal markers neurofilament 160 (NF-M) and SCG 10 (Stanke et al., 1999) . Therefore we analyzed whether Phox2 transcription factors are also sufficient for the induction of synaptotagmin I and neurexin I.
Three chick embryos infected with RCAS-Phox2a and two infected with RCAS-Phox2b virus as described in Stanke et al. (1999) were analyzed. In two embryos infected with RCAS-Phox2a and both infected with RCAS-Phox2b virus, ectopic cells positive for NF-M and SCG10 were abundantly found in the developing brachial nerve as described in Stanke et al. (1999) . In one embryo infected with RCAS-Phox2a no clusters of positive cells were observed due to a restricted viral infection pattern. In the RCAS-Phox2a-infected embryos showing ectopic neurofilament and SCG10-positive cell groups, clusters of synaptotagmin I and neurexin Ipositive cells were found in the same location (Fig. 7A-D) . In contrast, no positive cells were observed in the embryo lacking ectopic SCG10 and NF-M expression. Double in situ hybridization for SCG10 and myelin basic protein demonstrated the location of the ectopic neuronal cells in the brachial nerve of an RCAS-Phox2b-infected embryo (Fig.  7E,F) . The coexpression of neuronal and catecholaminergic properties was shown by double in situ hybridization for TH and synaptotagmin I in an RCAS-Phox2b-infected embryo (Fig. 8) . Whereas synaptotagmin I is expressed in TH-positive cells (Fig. 8A,B) , synaptotagmin II is not detectable (Fig.  8C,D) . The same expression pattern is found in sympathetic ganglia (Fig. 8E,F) . These data indicate that Phox2 overexpression can induce the expression of a specific set of neuronal genes in an environment that normally is not permissive for neuronal differentiation.
Discussion
Here we show that synaptotagmin I and neurexin I, two genes whose protein products are involved in neurotransmit-ter secretion, become detectable in differentiating sympathetic precursors shortly after induction of the noradrenergic neurotransmitter phenotype. BMP4, which can induce noradrenergic differentiation of precursors also promotes synaptotagmin I and neurexin I expression in vivo and in vitro. Comparison of synaptotagmin I and TH induction in neural crest cultures in vitro demonstrates that quantitative differences exist, indicating the participation of additional factors regulating the expression of synaptotagmin I and TH. Phox2 transcription factors also can induce expression of genes involved in neurotransmitter synthesis as well as neurotransmitter release. The data indicate that both sets of genes can be regulated by overlapping sets of growth and transcription factors during induction of the neuronal phenotype in differentiating sympathetic precursors.
The cells which are recruited by BMP4 and Phox2 overexpression to express noradrenergic and neuronal properties at ectopic locations are likely differentiating from multipotent neural crest-derived precursors that can be found in peripheral ganglia and nerve (see Stanke et al., 1999 , for detailed discussion). In addition, an excess of precursor cells can be found in the surroundings of the primary sympathetic ganglia (Schneider et al., 1999; UE, unpublished observations) . Such precursor cells, which die in the absence of appropriate differentiation and survival factors (Schneider et al., 1999; Pattyn et al., 1999) , may be rescued by the overexpression of BMP growth factors or Phox2 transcription factors. The different distribution of the ectopic cells after BMP4 or Phox2 overexpression (compare Figs. 4 and 7) may result from BMP effects on ganglion condensation (see below) and/or the interaction of BMPs with other growth factors not associated with Phox2 expression.
Our present findings extend the previous observations that the inductive properties of BMP growth factors are not limited to subclass-specific neuronal phenotypes. BMPs are already known to induce neuronal properties such as peripherin expression in neural crest stem cells (Shah et al., 1996) , and noggin treatment of chick embryos to block BMP action prevents expression of neurofilament in addition to noradrenergic properties in sympathetic precursor cells (Schneider et al., 1999) . Moreover, BMPs may support the differentiation of MAP2 and b-tubulin IIIpositive neurons from cerebral cortical precursors (Li et al., 1998; Mabie et al., 1999) . The results indicate that BMPs may, in a position-specific manner, induce neuronal differentiation cascades. In the case of sympathetic neurons, this includes the expression of the noradrenergic transmitter phenotype, constituents of the transmitter secretion apparatus, and other neuronal markers such as NF-M.
The small but significant delay in detectable expression of synaptotagmin I and neurexin I as compared to noradrenergic properties, however, indicates that differences exist in the regulation of these genes during sympathetic neuron development. Our data suggest that signals in addition to BMPs are involved in the differentiation process. These as yet uncharacterized factors seem to affect the expression of transmitter-synthesizing enzymes and constituents of the transmitter secretion apparatus differentially. This conclusion is supported by the distinct effects of cell density in the presence of BMP4 on tyrosine hydroxylase and synaptotagmin I expression in cultures of neural crest cells. Importantly, the lack of effect of increased cell density in the absence of exogenously added BMPs indicates that BMPs are the primary inducing signal required for synaptotagmin I expression. The observation that not only cell density but also the position of the cells in the wells of the culture dish affects synaptotagmin I expression suggests that a factor released by the cultured crest cells themselves interacts with BMPs to promote synaptotagmin I expression. In mammalian and avian neural crest cell cultures, cAMP levels influence noradrenergic induction by BMPs (Lo et al., 1999; Bilodeau et al., 2000) . Moreover, the induction by BMPs of neuronal properties such as peripherin expression and neurite formation can be completely uncoupled from noradrenergic induction in the absence of the adenylate cyclase activator forskolin (Shah et al., 1996) . These observations demonstrate that BMP signaling interacts with other signal transduction pathways during neuronal differentiation. The molecular nature of signals interacting with BMPs in the induction of constituents of the transmitter release apparatus remains to be determined. It will be of interest to see whether these signals and BMPs need to act simultaneously or sequentially.
Synaptotagmin I and neurexin I are both expressed in a variety of neuronal populations in the CNS and the PNS (Ushkaryov et al., 1992; Ullrich et al., 1994 Ullrich et al., , 1995 Püschel and Betz, 1995; Marquèze et al., 1995; Berton et al., 1997) . These include neuron populations in the ventral spinal cord (Püschel and Betz, 1995; Berton et al., 1997) which are remote from known BMP sources throughout development (Liem et al., 1995; Reissmann et al., 1996) and do not acquire catecholaminergic transmitter properties. The observations imply that synaptotagmin I and neurexin I expression can be induced in a number of neuron populations independently of BMPs. Similar considerations hold for the role of Phox2 transcription factors. Remarkably, Phox2a was cloned independently as transcriptional regulator of the NCAM gene (Valarché et al., 1993) and the DBH gene (Zellmer et al., 1995) . This strongly suggests that Phox2 transcription factors are involved in the regulation of both noradrenergic and transmitter phenotype-unrelated neuronal markers and provokes the question whether a similar binding site for Phox2 proteins exists in the synaptotagmin I and neurexin I promoter. An interesting parallel is observed after overexpression of neurogenin (ngn) transcription factors which are detectable in sensory but not sympathetic neurons of the peripheral nervous system (Sommer et al., 1996) . Virus-mediated ngn-1 overexpression in the chick embryo leads to the ectopic expression of neurofilament, neuron-specific tubulin, and other pan- (B) . No such signal is detectable after the second color reaction when a synaptotagmin II probe is used (D). This proves the specificity of the induction process as well as the complete inactivation of the alkaline phosphatase by the glycine buffer treatment after the first color reaction. (E) Synaptotagmin I expression in paravertebral sympathetic ganglia of the same embryo. The black signal after the second color reaction indicating synaptotagmin I expression covers all sites of TH expression which after the first color reaction were visible as red spots. (F) Lack of synaptotagmin II expression in paravertebral ganglia of the same embryo. The red signal resulted from the first color reaction and shows sites of TH expression. The lack of black signal after the second color reaction demonstrates that there is no detectable synaptotagmin II expression. Thus, TH, synaptotagmin I, and synaptotagmin II expression patterns correspond between sympathetic ganglion cells and ectopic catecholaminergic cells. Scale bar: 25 mm.
neuronal properties in addition to markers which are expressed with some specificity in sensory neurons (Perez et al., 1999) . Importantly, ngn-1 misexpression in Xenopus embryos induces the expression of neural specific proteins such as neuron-specific tubulin and the presynaptic proteins syntaxin and SNAP-25 (Olson et al., 1998) . These and our observations demonstrate that neuron subclass-specific transcription factors can affect the expression of subclass-specific genes as well as genes whose expression in neurons is much more widespread. These findings imply that genes encoding proteins involved in transmitter secretion may be regulated by different transcription factors in different neuronal populations.
Such conclusions contrast with the assumption that genes which are expressed in a large number of neuron populations, such as synaptotagmin I or neurexin I, may be regulated by a common mechanism. Indeed, the neuronrestrictive silencer factor NRSF/REST binds a DNA sequence element (NRSE) present in a large number of neuron-specific genes including synapsin I and synaptotagmin IV (for review see Schoenherr et al., 1996) . NRSF/ REST represses neuronal gene transcription in non-neuronal cells as a quasi-ubiquitous silencer in many tissues (Simpson, 1995) and is not expressed in the majority of differentiated neurons. The mechanisms through which this quasiubiquitous regulator interacts with subpopulation-specific regulators such as Phox2s are not known. One idea is that neuron-specific expression in sympathetic ganglia requires a combination of release from silencing by neuron-specific downregulation of NRSF/REST (or a related factor) with transactivation by neuronal subpopulation-specific transcription factors (such as Phox2).
The observation that neural crest cells differentiate neuronal and noradrenergic characters in the presence of BMP4, but form ganglion-like cell aggregates only after BMP withdrawal indicates that neuronal differentiation in continuous presence of BMP is incomplete. This is of interest, as the sympathetic cells in the primary ganglia, adjacent to the dorsal aorta as a source of BMPs, do not aggregate as densely as in the secondary sympathetic ganglia (Ernsberger et al., 1995 Reissmann et al., 1996; Schneider et al., 1999) . They rather form a loosely associated cluster of cells and eventually migrate to their final sites. This suggests that BMPs, even though they induce initial neuronal differentiation, may block advanced steps in neuronal development that allow the condensation of neurons into ganglia. In vivo, BMPs may compromise the aggregation of sympathetic cells as supported by the scattering of ectopic noradrenergic cells in chick embryos after BMP4 overexpression ; this study). The expression of BMP4 in primary sympathetic ganglia in addition to aorta-derived BMPs (McPherson et al., 2000) may prevent dense aggregation of sympathetic neurons in primary strands, while in secondary sympathetic ganglia BMP4 is expressed at very low levels if at all (Ernsberger, unpublished observations) and, thus, may not obstruct ganglion cell aggregation.
Our study suggests that the action of BMP growth factors and Phox2 transcription factors is necessary for the regulation of at least two different sets of neuronal genes: the genes coding for neurotransmitter synthesizing enzymes and those coding for proteins involved in neurotransmitter secretion. These observations lead to several questions. What is the molecular cascade from BMP binding to Phox2 action and to target gene expression, and does it differ between different target genes? What is the equivalent regulatory pathway in other classes of neurons that do not receive BMP signals, do not express Phox2 transcription factors, or both? The current results support the conclusion that these site-specific growth and differentiation factors induce not only neuronal properties that are specifically expressed at these sites. Instead, these factors can also induce neuronal properties expressed in a variety of neuronal populations located at distinct sites, including those not within reach of BMP growth factors or Phox2 transcription factors. Consequently, different growth and transcription factors should induce the expression of these neuronal differentiation genes in different neuronal populations.
Materials and methods
cDNAs
Chick synaptotagmin I and II (Campagna et al., 1997) and chick neurexin I (Patzke and Ernsberger, 2000) are available as cDNAs in pGEM7 and pBluescript, respectively. Chick tyrosine hydroxylase is available as cDNA in pBluescript (Ernsberger et al., 1995) . Chick DBH is available as PCR fragment in pBluescript . NF-M and SCG10 are available as described (Stanke et al., 1999) . Chick preprotachykinin cDNA is a kind gift of Dr. Y.-A. Barde (MPI f. Psychiatrie, Martinsried, Germany). Chick myelin basic protein cDNA is a kind gift of Dr. S. Heller (Massachusetts Eye and Ear Infirmary, Boston, USA).
In situ hybridization
Radioactive in situ hybridizations were performed as described in Ernsberger et al. (1995) .
Non-radioactive in situ hybridization was performed as described in Ernsberger et al. (1997 Ernsberger et al. ( , 2000 . Synaptotagmin I and neurexin I riboprobes were available with different length ranging from approximately 300 bases to 3 kb in length. Usually the longest probes encompassing coding and 3 0 UTR sequences were used as they gave the best signal to background ratio. Specificity of the signals was verified by comparison to hybridizations with sense probes, comparison to the signals produced with the 3 0 UTR probes, and, in the case of synaptotagmins, comparison with the signals produced by a synaptotagmin II riboprobe of 230 bases length (Fig. 2) . For double in situ hybridization, fluorescein-labeled TH or SCG10 riboprobes and DIG-labeled synaptotagmin I or myelin basic protein riboprobes were used as described .
Neural crest cell cultures
Cell cultures from neural crest cells were obtained as described in Reissmann et al. (1996) . Human recombinant BMP4 (Genetics Institute) was added at 10 ng/ml on the day when the resuspended cells were plated as dissociated cell suspension. The growth factor was present until the end of the culture period (6 days after preparation of the tissue). Alternatively, as described in the text, BMP4 was removed after 1 day by repeatedly washing the cells with culture medium in the absence of additional growth factors, or it was blocked by addition of medium conditioned by noggin expressing CHO cells. After a total culture period of 6 days, cells were fixed for 15 min in 4% paraformaldehyde in phosphate-buffered saline and propagated for in situ hybridization as described in Ernsberger et al. (1997) .
Viral infections
Infections of chick embryos with RCAS-BMP4, RCASPhox2a or RCAS-Phox2b were performed as described in Ernsberger et al. (2000) and Stanke et al. (1999) , respectively. Embryos were implanted with infected fibroblasts at day 2 and fixed for in situ hybridization at days 5 and 8. At day 8 the effects are stronger than at day 5 and larger patches of ectopic noradrenergic cells are available for analysis (compare Reissmann et al., 1996; Ernsberger et al., 2000) .
